Cancer Research and Treatment10.4143/crt.2008.40.3.1012008403101Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast CancerJung Hwan Kim, Sung Yong Oh, Hyuk-Chan Kwon, Suee Lee, Sung-Hyun Kim, Dae-Cheol Kim, Jin-Hwa Lee, Hyung-Sik Lee, Se-Heun Cho, Hyo-Jin Kim,
Breast Diseases: A Year Book Quarterly10.1016/j.breastdis.2011.10.0142011224413-415Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancerR. Rozner, A.D. Seidman,
Cancer Chemotherapy and Pharmacology10.1007/s00280-012-1824-z20126951345-1352A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancerN. Karachaliou, Ch. Kouroussis, P. Papakotoulas, K. Kalbakis, K. Tryfonidis, N. Vardakis, E. Poppis, V. Georgoulias, D. Mavroudis,,
European Journal of Cancer Supplements10.1016/s1359-6349(05)80760-8200532129-130463 PUBLICATION Gemcitabine (GEM) plus oxaliplatin (LOHP) as salvage treatment in anthracycline and taxane pretreated patients with advanced breast cancer (ABC),
Journal of Breast Cancer10.4048/jbc.2014.17.4.3392014174339Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer PatientsJung Sun Kim, In Hae Park, Keun Seok Lee, Jungsil Ro,,
Breast Diseases: A Year Book Quarterly10.1016/s1043-321x(07)80372-92007183313Phase II and Pharmacological Study of Oral Paclitaxel (Paxoral) Plus Ciclosporin in Anthracycline-Pretreated Metastatic Breast CancerR.M. Elledge,
European Journal of Cancer Supplements10.1016/s1359-6349(05)80751-7200532127454 PUBLICATION phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC),
Clinical Breast Cancer10.3816/cbc.2008.n.026200883234-241Phase I/II Study of Ixabepilone plus Capecitabine in Anthracycline–Pretreated/Resistant and Taxane-Resistant Metastatic Breast CancerCraig Bunnell, Linda Vahdat, Lee Schwartzberg, Julie Gralow, Judith Klimovsky, Valerie Poulart, Ronald Peck, Eva Thomas,
Cancer Chemotherapy and Pharmacology10.1007/s00280-011-1728-32011692515-522An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II studyZhonghua Wang, Jingsong Lu, Shiangjiin Leaw, Xiaonan Hong, Jialei Wang, Zhimin Shao, Xichun Hu,,
Cancer Treatment Reviews10.1016/s0305-7372(05)80004-0200531S17-S22Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?C LEVY, P FUMOLEAU,